Clifford Group’s CVS Health CVS Stock Holding History

Clifford Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-7,527	Closed	-$445K	–	75
2024 Q2	$445K	Sell	7,527 -408	-5%	-$25.5K	0.36%	48
2024 Q1	$633K	Buy	7,935 +850	+12%	+$64.9K	0.52%	40
2023 Q4	$559K	Sell	7,085 -782	-10%	-$55.7K	0.52%	40
2023 Q3	$549K	Buy	7,867 +711	+10%	+$50.4K	0.6%	33
2023 Q2	$495K	Buy	7,156 +1,846	+35%	+$131K	0.53%	47
2023 Q1	$395K	Buy	5,310 +286	+6%	+$24K	0.48%	48
2022 Q4	$468K	Buy	+5,024	New	+$485K	0.58%	43

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Clifford Group's CVS Position: Q3 2024 in Review

Clifford Group sold out of CVS Health (CVS) in Q3 2024, closing a stake of 7,527 shares — an estimated $445K sold.

Clifford Group first reported a position in CVS in Q4 2022 and held it in 7 quarters. The position peaked at $633K in Q1 2024. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

Clifford Group reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
Clifford Group sold 7,527 CVS Health shares in Q3 2024, an estimated $445K.
Clifford Group first reported a position in CVS Health in Q4 2022 and held it in 7 quarters.
Clifford Group's CVS Health position peaked at $633K in Q1 2024.
1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Clifford Group's 13F filing for Q3 2024, filed 12 Nov 2024.